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Summary 1 
Alternative splicing, a mechanism of post-transcriptional RNA processing whereby a single gene can encode multiple 1 
distinct transcripts, has been proposed to underlie morphological innovations in multicellular organisms. Genes with 2 
developmental functions are enriched for alternative splicing events, suggestive of a contribution of alternative splicing to 3 
developmental plasticity. The role of alternative splicing as a source of transcript diversification has previously been 4 
compared to that of gene duplication, with the relationship between the two extensively explored. Alternative splicing is 5 
reduced following gene duplication with the retention of duplicate copies higher for genes which were alternatively 6 
spliced prior to duplication. Furthermore, and unlike the case for overall gene number, the proportion of alternatively 7 
spliced genes has also increased in line with the evolutionary diversification of cell types, suggesting alternative splicing 8 
may contribute to the complexity of developmental programmes. Together these observations suggest a prominent role 9 
for alternative splicing as a source of functional innovation. However, it is unknown whether the proliferation of 10 
alternative splicing events indeed reflects a functional expansion of the transcriptome or instead results from weaker 11 
selection acting on larger species, which tend to have a higher number of cell types and lower population sizes. 12 
 1 
1 
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Introduction 2 
Since life first appeared on Earth, organisms have constantly changed and diversified to populate most environments. 3 
Although far outnumbered by single-celled organisms, multicellular organisms have evolved some of the most complex 4 
structures known, the consequence of elaborate and highly regulated programmes which allow their development from a 5 
single fertilised egg. The successive refinement of these programmes, in individual lineages over many generations, 6 
underlies the observed phenotypic diversity of the extant multicellular species. All observed phenotypic adaptations are, 7 
ultimately, encoded in the genome – but identifying which changes in the DNA underlie the evolution of novel  8 
phenotypes  has proven to be a difficult task. Here we review the potential relevance of alternative splicing, a mechanism 9 
of post-transcriptional RNA processing, in the regulation of various biological processes and the evolution of novel 10 
phenotypes. 11 
Alternative splicing is a process whereby multiple functionally distinct transcripts are encoded from a single gene by the 12 
selective removal or retention of exons and/or introns from the maturing RNA [1-4]. The process is highly regulated, 13 
involving trans-acting splicing factors and cis-acting regulatory motifs (see [5] for review) and so is susceptible to 14 
hereditary and somatic mutations [6]. Alternative splicing is common in many eukaryote lineages, including metazoans 15 
[7], fungi [8] and plants [9], with deep transcriptome sequencing of the human genome showing over 95% of multi-exon 16 
genes produce at least one alternatively spliced isoform [10, 11]. 17 
Alternative splicing has been found to be involved with numerous processes in multiple taxa including the virulence of 18 
pathogenic fungi [8], the flowering time of Arabidopsis [12], penile erection [13] and thermogenesis [14] in mice, and the 19 
neuronal development of primates [15, 16], rats [17], worms [18] and flies [19]. Many single-gene studies have also 20 
characterised the role of alternative splicing in various cellular processes (see [5, 20] for reviews), with a recent single-21 
cell study detecting differential alternative isoform expression throughout the cell cycle [21]. Disruption or dysregulation 22 
of alternative splicing has also been associated with pathological states (see [22, 23] for reviews) further supporting a 23 
functional contribution of this process. Aberrant alternative splicing has been linked to uncontrolled cell proliferation and 24 
chemotherapy resistance in cancer cell lines [24-28]. More broadly, genome-wide association studies in humans (which 25 
detect phenotype-predictive polymorphisms by genotyping affected and non-affected individuals) have uncovered a large 26 
number of intronic polymorphisms as significant predictors of disease susceptibility [29], many of which have been found 27 
to disrupt correct alternative splicing (e.g. [30-32]). 28 
Some studies have associated alternative splicing with developmental plasticity and early speciation. Differential 29 
methylation patterns (which affect gene regulation) are associated with alternative splicing in bees which produce 30 
alternative castes [33]. Similarly, human body lice are thought to have emerged as an alternative morph of human head 31 
lice since the use of clothing became widespread. While there were no significant differences detected in which genes 32 
were expressed between the two morphs [34], morph-specific alternative splicing events were detected for over a 33 
thousand genes [35]. In particular, body lice specific alternative splicing events were enriched in genes associated with 34 
developmental gene ontology terms [35]. A comparable study of two mice subspecies that diverged about half a million 35 
years ago were also found to differ in their alternative splicing profiles [36]. 36 
 37 
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Alternative splicing, functional innovation and the evolution of complexity in 38 
developmental programmes 39 
Alternative splicing has been proposed to contribute to the evolution of novel phenotypes [37-40] as a small number of 40 
mutations (those in the 5’ or 3’ splice sites, for instance), can give rise to alternative splicing isoforms consisting of novel 41 
combinations of exons from existing genes [41, 42], providing an opportunity for the evolution of new functions. This has 42 
prompted comparisons between alternative splicing and gene duplication, widely recognised as a major source of 43 
phenotypic innovation [43, 44] (Holland, in this issue). The number of alternatively spliced isoforms per gene can 44 
decrease after a gene duplication event [45] suggesting that alternative splicing and gene duplication are to some extent 45 
equivalent mechanisms regulating transcript diversity. Several studies have reported that larger gene families (i.e. with 46 
more paralogues) have fewer alternative splicing events per gene compared to smaller families [46-48], further consistent 47 
with a reciprocal link. However, these correlations may also be explained by other factors, such as gene age (genes 48 
progressively acquire new splice variants over time, although the rate of increase is slowed by stronger purifying 49 
selection acting upon older genes) [49]. Figure 1 shows a model of the interplay between alternative splicing and gene 50 
duplication. 51 
Alternative splicing may also promote the retention of duplicated genes by facilitating subfunctionalisation [50] where 52 
gene copies acquire reciprocal mutations so that the duplicate copies fulfil the original’s gene function preventing them 53 
from becoming pseudogenes – the fate of most duplicate genes [51]. Single gene studies provide examples where 54 
duplicated copies are retained and diverge to resemble alternatively spliced isoforms produced by the ancestral single 55 
copy gene. For instance, in the vertebrate genome, which underwent at least one round of whole genome duplication early 56 
in its evolution [52, 53], there are three copies of the neuromuscular gene troponin I, each expressed in a distinct muscle 57 
type. These three genes are broadly equivalent to the alternatively spliced isoforms – also expressed in distinct muscle 58 
types – found in the urochordate Ciona intestinalis: a sister taxon to vertebrates, not affected by the whole genome 59 
duplication events, wherein troponin I is a single-copy gene [54]. Other examples of duplicate genes retained and 60 
evolving to resemble ancestral alternative splicing isoforms preceding gene duplication are characterised in the MITF 61 
[55], FoxP [56], and Syn-Timp families [57]. Moreover, two genome wide studies have shown that alternatively spliced 62 
genes are more likely to be found as duplicate copies in vertebrates [58] and fungi [59]. 63 
Soon after the publication of the human genome sequence – which revealed a lower than expected number of protein 64 
coding genes – alternative splicing was proposed as a candidate to explain the diversification in the number of cell types 65 
observed in some eukaryotic lineages (a higher number of cell types in a given species is assumed to reflect increased 66 
organism complexity). As gene duplication has long been associated with functional innovation, it was initially assumed 67 
that overall gene number should correlate with the number of cell types [38, 60]. Gene duplication rates, however, failed 68 
to reflect the diversification of cell types observed in several eukaryotic lineages. There is a significant correlation 69 
between the two but weaker than expected and only moderately better if the analysis is restricted to metazoans [61]. 70 
Whole genome duplication events at the base of the vertebrate lineage [52, 53], which have the highest number of cell 71 
types among eukaryotes, have comparable numbers of genes to most invertebrates (that have not undergone whole 72 
genome duplication). The poor relationship between a species’ cell type diversity and its total gene number has become 73 
known as ‘the G-value paradox’ [60]. 74 
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Although other genomic features have been shown to correlate with cell type number and may be important contributors 75 
to the evolution of complexity (i.e. [61, 62]), alternative splicing – as a mechanism allowing transcript diversification in 76 
the absence of increases in gene number – is a prime candidate to explain the G-value paradox [37, 38, 40, 63]. 77 
Comparative studies have reported marked differences in the prevalence of alternative splicing across eukaryotic lineages 78 
as well as a significant correlation between alternative splicing and the number of cell types per species [39, 61, 62, 64]. 79 
These results are in principle consistent with an adaptive role of alternative splicing in determining a genome’s functional 80 
information capacity and facilitating transcript diversification in species with greater numbers of cell types. It should be 81 
noted that some of the studies exploring changes in alternative splicing across evolutionary time and its association with 82 
cell type diversification have not corrected for unequal transcript coverage between species (which distort estimates of 83 
alternative splicing [37-39, 61, 64]) leading to inconclusive results [61, 64]. 84 
 85 
Functional molecular consequences of alternative splicing 86 
It is clear that alternative splicing makes a large contribution to the number of distinct transcripts produced in many 87 
species – but the contribution of alternative splicing to the proteome is less clear [65]. Alternative splicing can modify the 88 
properties of encoded proteins, including the set of domains it contains, its binding properties, stability, intracellular 89 
localization and enzymatic activity [66-68]. Genes with higher levels of alternative splicing tend, in general, to have a 90 
higher number of protein-protein interactions [69]; those with alternative splicing events which are tissue specific also 91 
tend to have a more central position in PPI networks [70]. Furthermore, alternatively spliced regions preferentially encode 92 
residues found at the protein surface [71], which often contain interaction sites for proteins and their binding partners 93 
[72]. In addition, a gene’s alternatively spliced regions are more likely to encode disordered regions of protein (i.e. which 94 
have multiple stable configurations) [73]. These regions may also experience stronger selection for functions related to 95 
binding – flexible sensors are more adaptable than rigid ones [74, 75] – supporting an association of alternative splicing 96 
with the evolution of regulatory networks [76] (see [77] for a review of the regulatory circuits through which alternative 97 
splicing may act to regulate expression). Indeed, a comparison of the protein-protein interaction profiles of hundreds of 98 
protein isoform pairs suggests that the majority share less than half of their interactions – the principal and alternative 99 
isoforms belong to separate functional modules, suggesting functional differences between the set of splicing isoforms 100 
produced by the same gene [65]. Taken together, these observations are consistent with a role of alternative splicing in 101 
the diversification of the proteome and the modulation of protein-protein interactions. 102 
Despite the various examples of alternatively spliced proteins having distinct functional roles, it is likely that a large 103 
proportion, or indeed the majority, of alternative splicing isoforms do not result in functional proteins [78-82]. An 104 
analysis of eight large-scale human proteomics experiments – collectively interrogating over 100 tissues, cell lines and 105 
developmental states with tandem mass spectrometry – found only 0.4% of the detected peptides are derived from 106 
alternatively spliced transcripts [83]. It is possible that the primary functional role of an alternative splicing event – if 107 
there is one at all – need not be at the protein level. For instance, alternative transcripts with ‘poison cassettes’ – exons 108 
with early in-frame stop codons – will never produce protein but instead down-regulate expression by diverting a 109 
proportion of pre-mRNA into the nonsense-mediated decay (NMD) pathway, a mechanism known as RUST (regulated 110 
unproductive splicing and translation) [84-86]. 111 
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 112 
Selection versus genetic drift and the proliferation of alternative splicing 113 
The increasing prevalence of alternative splicing in eukaryotes with higher number of cell types may be explained by 114 
neutral processes. In general, species with higher numbers of cell types also tend to have lower effective population sizes 115 
(the number of breeding individuals contributing to the next generation), which is thought to reduce the strength of 116 
selection relative to genetic drift [87, 88] (but see [89-91]). This is because in smaller populations there is a greater 117 
likelihood of neutral or slightly deleterious mutations – including those affecting splicing regulation – reaching fixation. 118 
Thus, it is expected that the number of ‘noisy’ transcripts (those arising by erroneous splice site recognition) should be 119 
higher in species with lower effective population sizes resulting from mutations which introduce new but non-functional 120 
alternative splicing events, or that reduce the effectiveness of accurate intron splicing, increasing stochastic noise in RNA 121 
processing [78] – physicochemical fluctuations in the cellular environment that vary spliceosome efficiency [92]. As 122 
such, a reasonable null expectation is that many of the observed alternative splicing events are selectively neutral and that 123 
their existence is as a transient state, prior to being fixed or lost due to drift. 124 
In the absence of experimental verification of each splicing event identified, the general functional contribution of 125 
splicing events is hard to assess. Under a drift model, it would be expected that the relationship between alternative 126 
splicing and cell type number should be explained by variations in effective population size. Our previous work suggests 127 
a strong relationship between alternative splicing and cell type number irrespective of effective population size [62], 128 
however, this finding is limited by the small quantity of effective population estimates available (n = 12). Although 129 
compendia of effective population size data have developed substantially [93, 94], there is still minimal overlap with the 130 
set of species for which comparative alternative splicing levels have been estimated. Taking adult body weight [95], 131 
average age at sexual maturity [96], and generation time [97] as proxies of effective population size [89] as well as 132 
‘effective information’ (a value derived from principles of information theory as ‘the minimal amount of genomic 133 
information needed to construct an organism’) [98], the correlation of alternative splicing and cell type number remains 134 
significant [62] (Table 1 and Supplementary Table 1).  135 
More complex species with higher number of cell types will also have longer generation times. If every time a genome is 136 
replicated there is a chance of error, then ‘complex’ species (which tend to have longer generation times and smaller 137 
effective population sizes), should have fewer replications per unit time [99]. We can speculate that consequently, 138 
mutations affecting splicing regulation – such as a single nucleotide polymorphism (SNP) that creates a new splice site 139 
[100] – are less likely to arise, but that new splice sites are also less likely to be eliminated (as the strength of drift relative 140 
to selection is higher). We can also predict that in ‘complex’ species, to disrupt, or create de novo, a splice site is to hit a 141 
large mutational target: the binding sites for proteins involved in exon recognition (necessary for accurate intron removal) 142 
are relatively large (approx. 30bp [78]), the binding sites for RNA-binding proteins (RBPs) are, although short, numerous 143 
[101], and the introns (in which new splice sites may arise) are longer in organisms with lower effective population sizes 144 
[88]. 145 
Another way to assess the functional contribution of alternative splicing is to examine the conservation of alternatively 146 
spliced events across evolution. A base-by-base analysis of the genotype-phenotype relationship for an alternatively 147 
spliced human exon demonstrated, that nucleotides which affect splicing regulation are dispersed the entire length of the 148 
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exon and so any mutations could conceivably alter the accuracy of splicing [102]. This predicts the rapid divergence of 149 
alternative splicing events between species, except if they are selectively constrained. Conserved patterns of differential 150 
exon usage have been observed for a proportion of genes in comparisons of humans and mice [103-105], among primates 151 
[15, 106] and between grapevine cultivars [92]. Conserved alternative splicing profiles have also been identified in a 152 
lineage-, species- and tissue-specific manner among vertebrates [107, 108]. These studies suggest that in some of the 153 
species with the highest number of cell types, a significant number of the alternative splicing events are functional. 154 
However, whether the proportion of conserved alternative splicing events per species co-varies with the overall genome-155 
wide prevalence of alternative splicing or with species complexity is unknown. In any case, increasing noise in alternative 156 
splicing regulation may, in itself, provide the substrate for a selective process and have adaptive significance to 157 
phenotypic plasticity, as it creates a ‘landscape of opportunities’ [109, 110]. 158 
It is likely that the observed distributions of alternative splicing events have been shaped by both adaptive and neutral 159 
processes, but further investigation is required to determine the evolutionary force of greatest significance. 160 
 161 
Concluding remarks 162 
The molecular drivers of development of an adult organism from a fertilised egg have been a matter of intense study over 163 
many decades. The discovery of DNA as the molecule containing the heritable information paved the way to many 164 
discoveries into the shared molecular pathways governing the development of a range of phenotypic traits. Advances in 165 
the ‘post-genomic era’ (characterised by its rapid accumulation of genomic, transcriptomic and proteomic profiling data) 166 
have allowed a better understanding of what molecular characteristics best explain the phenotypic differences between 167 
organisms. Perhaps more importantly, comparative studies are also helping to piece together the role of different aspects 168 
of genome evolution in the context of functional and phenotypic innovations. Alternative splicing provides an ideal 169 
mechanism for genomic novelty as it can result from a small number of mutations. Furthermore, while changes in the 170 
coding regions of genes will affect all transcripts containing this region, alternative splicing events can be expressed in 171 
highly specific conditions such as specific cell types or developmental stages. Here, we have summarised the evidence for 172 
a prominent role for alternative splicing in functional genomic evolution. Unlike gene number [61], alternative splicing is, 173 
at present, the foremost genomic predictor of increases in developmental complexity (using the number of cell types as 174 
proxy) [62]. It remains an open question as to what extent the association of alternative splicing and the number of 175 
distinct cell types is functional, or potentially a by-product of the fact that more complex organisms have lower effective 176 
population sizes and so are subject more strongly to drift. 177 
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Tables 
Table 1. Spearman Rho correlation coefficients between the average number of alternative splicing events per gene (ASL) 
and the proportion of genes alternatively spliced (ASP) with two measures of complexity (effective information and cell 
type number) correcting by various estimates and proxies of effective population size (Ne). 
  ASL vs. Ne 
ASL vs. complexity 
correcting by Ne ASP vs. Ne 
ASP vs. complexity 
correcting by Ne 
    
Effective 
information 
Cell type 
number   
Effective 
information 
Cell type 
number 
Ne.μ, calculated using pi/π 0.22 0.90 0.88 0.27 0.86 0.93 
Ne.μ, calculated using S 0.28 0.88 0.88 0.34 0.83 0.93 
Ne.μ, calculating using eta/η 0.26 0.90 0.88 0.32 0.86 0.93 
Adult body weight 0.64 0.21 0.93 0.39 0.55 0.89 
Average age at sexual maturity 0.93 0.56 0.97 0.88 0.79 0.76 
Generation time 0.70 0.86 0.78 0.73 0.85 0.82 
Notes. Significant correlation coefficients significant at p < 0.05 are marked in bold. See supplementary table 1 for 
underlying data and sources. 
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Figure caption 
Figure 1. Model of the role of alternative splicing as a source of functional genomic innovation and retention of duplicate 
genes by facilitating sub-functionalisation. Novel alternative splicing events allow single-copy gene A to produce two 
protein isoforms, each optimised for expression in a specific tissue. After a duplication event the alternatively spliced 
exon is maintained in gene A2 but lost in A1. Divergence in the promoter areas of the duplicated genes lead to changes in 
gene expression profiles over time so that each gene is now only expressed in one tissue, mirroring the expression profile 
of the two isoforms of the original ancestral single-copy gene. 
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